Back

Amyloid-beta increases MBP and MOBP translation in oligodendrocytes through dysregulation of hnRNP A2 dependent RNA dynamics

Gaminde-Blasco, A.; Senovilla-Ganzo, R.; Balantzategi, U.; Garcia-Moreno, F.; Matute, C.; Baleriola, J.; Alberdi, E.

2024-04-19 molecular biology
10.1101/2024.04.19.590214 bioRxiv
Show abstract

Oligodendrocyte dysfunction, myelin degeneration, and white matter structural alterations are critical events in Alzheimers disease (AD) that contribute to cognitive decline. A key hallmark of AD, A{beta} oligomers, disrupt oligodendrocyte and myelin homeostasis, but a comprehensive global analysis of the mechanisms involved is lacking. Here, transcriptomic profiling of A{beta}-exposed oligodendrocytes revealed widespread gene expression changes, particularly affecting pathways related to RNA localisation. Among the genes identified, we focused on Hnrnpa2/b1, the gene encoding the hnRNP A2 protein, which is essential for RNA transport and translation of myelin proteins. We confirmed aberrant upregulation of hnRNP A2 in hippocampal oligodendrocytes from post-mortem human brains of early-stage AD patients, A{beta}-injected mouse hippocampi and A{beta}-treated disrupting cells in vitro. RIP-seq analysis of the hnRNP A2 interactome revealed attenuated interactions with Hnrnpk and Hnrnpa2/b1, while interactions with Mbp and Mobp were enriched, suggesting changes in RNA metabolism of molecules associated with mRNA transport of myelin proteins. A{beta} increased the total number and dynamics of mRNA-containing granules, facilitating local translation of the myelin proteins MBP and MOBP and attenuating Ca2+ signalling. These findings suggest that A{beta} oligomers disrupt RNA metabolism mechanisms crucial for oligodendrocyte myelination through dysregulation of hnRNP A2 and myelin protein levels, potentially affecting oligodendroglia Ca2+ homeostasis. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=126 SRC="FIGDIR/small/590214v1_ufig1.gif" ALT="Figure 1"> View larger version (42K): org.highwire.dtl.DTLVardef@19e046eorg.highwire.dtl.DTLVardef@134f15corg.highwire.dtl.DTLVardef@d1f8aaorg.highwire.dtl.DTLVardef@11c97af_HPS_FORMAT_FIGEXP M_FIG GRAPHICAL ABSTRACT C_FIG

Matching journals

The top 1 journal accounts for 50% of the predicted probability mass.

1
Neurobiology of Disease
134 papers in training set
Top 0.1%
55.8%
50% of probability mass above
2
Frontiers in Aging Neuroscience
67 papers in training set
Top 0.7%
4.6%
3
Alzheimer's Research & Therapy
52 papers in training set
Top 0.6%
3.9%
4
Cell Reports
1338 papers in training set
Top 20%
2.2%
5
Annals of Neurology
57 papers in training set
Top 0.9%
2.0%
6
Nature Communications
4913 papers in training set
Top 48%
1.9%
7
iScience
1063 papers in training set
Top 13%
1.8%
8
eLife
5422 papers in training set
Top 39%
1.8%
9
Life Science Alliance
263 papers in training set
Top 0.6%
1.3%
10
Alzheimer's & Dementia
143 papers in training set
Top 2%
1.3%
11
International Journal of Molecular Sciences
453 papers in training set
Top 11%
1.2%
12
Molecular Psychiatry
242 papers in training set
Top 3%
1.0%
13
Cells
232 papers in training set
Top 5%
0.8%
14
Advanced Science
249 papers in training set
Top 17%
0.8%
15
Frontiers in Neuroscience
223 papers in training set
Top 7%
0.8%
16
Acta Neuropathologica Communications
81 papers in training set
Top 1%
0.8%
17
Molecular Neurodegeneration
49 papers in training set
Top 1.0%
0.7%
18
Translational Psychiatry
219 papers in training set
Top 4%
0.7%
19
Frontiers in Cellular Neuroscience
79 papers in training set
Top 2%
0.7%
20
npj Genomic Medicine
33 papers in training set
Top 1%
0.7%
21
Communications Biology
886 papers in training set
Top 28%
0.7%
22
Nature Aging
51 papers in training set
Top 2%
0.7%
23
Immunity
58 papers in training set
Top 5%
0.7%
24
Journal of Alzheimer's Disease
43 papers in training set
Top 1%
0.7%
25
Aging Cell
144 papers in training set
Top 4%
0.5%
26
The EMBO Journal
267 papers in training set
Top 7%
0.5%
27
Scientific Reports
3102 papers in training set
Top 79%
0.5%